Cultivated Biosciences: Pioneering the Future of Dairy Alternatives
March 10, 2024, 7:53 pm
Cultivated Biosciences, a biotech food startup based in Zurich, Switzerland, recently secured $5 million in Seed funding to accelerate the development of their innovative yeast cream. Led by CEO Tomas Turner, the company is revolutionizing the dairy industry with a yeast-derived cream that mimics the taste and texture of traditional dairy products without any additives.
The yeast cream, produced through fermentation, contains fats, proteins, and fibers all sourced from yeast, creating a microstructure that closely resembles milk fat droplets. This breakthrough ingredient has already been validated in products like coffee creamers and ice cream, showcasing its potential for widespread adoption in the food industry.
With plans to launch in the US market in 2025 and the European market in 2026 pending regulatory approval, Cultivated Biosciences is poised to disrupt the dairy industry and offer consumers a sustainable and delicious alternative to traditional dairy products. The company's unique production process, which involves yeast biomass fermentation, sets it apart from other dairy alternatives by being non-GMO, cost-effective, and easily scalable.
Supported by investors like Navus Ventures, Founderful, and Joyful VC, Cultivated Biosciences is on a mission to make alternative dairy products appealing to traditional dairy consumers while reducing CO2 emissions from dairy production. Recognized as one of the Top 100 Swiss Startups and a winner of Venture Kick, the company is at the forefront of innovation in the plant-based food industry.
With a team of dedicated professionals including Co-Founder & CTO Dimitri Zogg and Chief Commercial Officer Lucie Rein, Cultivated Biosciences is poised to lead the way in sustainable food production and offer consumers a guilt-free indulgence with their revolutionary yeast cream.
The yeast cream, produced through fermentation, contains fats, proteins, and fibers all sourced from yeast, creating a microstructure that closely resembles milk fat droplets. This breakthrough ingredient has already been validated in products like coffee creamers and ice cream, showcasing its potential for widespread adoption in the food industry.
With plans to launch in the US market in 2025 and the European market in 2026 pending regulatory approval, Cultivated Biosciences is poised to disrupt the dairy industry and offer consumers a sustainable and delicious alternative to traditional dairy products. The company's unique production process, which involves yeast biomass fermentation, sets it apart from other dairy alternatives by being non-GMO, cost-effective, and easily scalable.
Supported by investors like Navus Ventures, Founderful, and Joyful VC, Cultivated Biosciences is on a mission to make alternative dairy products appealing to traditional dairy consumers while reducing CO2 emissions from dairy production. Recognized as one of the Top 100 Swiss Startups and a winner of Venture Kick, the company is at the forefront of innovation in the plant-based food industry.
With a team of dedicated professionals including Co-Founder & CTO Dimitri Zogg and Chief Commercial Officer Lucie Rein, Cultivated Biosciences is poised to lead the way in sustainable food production and offer consumers a guilt-free indulgence with their revolutionary yeast cream.